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Growing points in medicine tend to occur
mainly at the interfaces between disciplines
and part of the phenomenon is the genera-
tion of " in groups ". Since by definition we
are all out of most "in groups ", keeping up
to date is often impossible and one can easily
overlook quite important developments. In
oncology, for example, relevant articles
appear in specialist journals devoted to
radiobiology, pharmacology, virology, im-
munology and genetics while clinical journals
carry many articles of oncological interest.
Abstracting services provide a partial solu-
tion to the problem ofgetting up to date, but
paradoxically the appearance of new special-
ist journals covering contiguous areas of
classic studies may be of great value. Such
is perhaps the case with immunogenetics, a
subject which involves antigenic polymor-
phisms and has recently come of age in
studies of the genetic control of immune
responsiveness and of antibody structure.
There is much of interest in immunology and
in genetics to cancer studies, particularly the
antigenicity oftumours and the ability ofthe
host to respond to them. The immuno-
logical and genetic interactions between
oncogenic viruses, host genotypes, somatic
mutations and environmental mutagens are,
with cell kinetics and the genetic control of
differentiation, areas of great interest in
fundamental oncological research.
In his editorial introduction to Volume I,
Number 1 of the Journal of Immunogenetics,
Dr Bauer quite rightly includes workers in
cancer research as being among those likely
to be interested in this new journal. How-
ever, of the 6 articles in this first issue of
Immunogenetics only one, that by Falk and
Osaba, on the association of HL-A with
Hodgkin's disease, is obviously related to a
cancer. This should not put oncologists off,
as the connection with cancer may be more
subtle and the first article by Wang and
Fudenburg on IgA is a good example. This
deals with the development of ideas on the
evolution of immunoglobulins, made possible
by the studv of myeloma globulins. An
understanding of the structure and genetic
control of the synthesis of immunoglobulins
and of the nature of their specificity is being
slowly developed and is important in our
understanding ofthe way in which antibodies
may paradoxically " protect " tumours, or
alternatively may be instrumental in the
destruction of tumour cells. Similarly, in a
later article Festenstein and his colleagues
report some of their work on the activation
of mouse effector cells. It is believed that
similar cells may in certain circumstances be
destructive to tumour cells and are the basis
for much current research in oncology. The
genetic locus studied by Festenstein is
closely linked to, but separate from, other
components of the major histocompatibility
locus of the mouse, H-2. Since this is now
generally accepted as being homologous with
human HL-A, the relevance of this work to
man is clear. The final paper in the first
number of Immunogenetics is a discussion of
Ir (immune response) gene function by
Marchalonis, Morris and Harris, in which it is
suggested that the products of these genes
may act to cover up self antigens and allow
an immune response to " foreign " antigens
(and perhaps tumour antigens) with which
they crossreact.
Few would dispute the relevance of
immunogenetics in cancer and one must
welcome the appearance of this new journal.
However, it remains to be seen whether this
journal will include many cancer orientated
articles and whether a balance canbeobtained
between good review articles and detailed
descriptions of new data. Many people,
experts as well as those without formal train-
ing in either genetics or immunology, would
undoubtedlygreatlyappreciatesuchajournal.
R. HARRIS
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This volume presents the 12 formal papers
presented to that Conference, 3 papers onBOOK REVIEWS
eachi of' fourl to)ical subjects in the field of
cancer research: endogenous virus, environ-
mental factors, tumour immunology and
chemotherapy. Each batch of 3 papers
includes one selected for its clinical implica-
tions, to ensure the interest of clinicians. It
will be appreciated that 3 papers give a very
restricted coverage of each topic.
The rest of the conference consisted of
informal discussion Workshops under 20
different headings, none of which is published
in tfhese Proceedings.
Endoyetious riruses
Zur Hausen describes the detection of
E1B virus in the epithelial cells ofnasopharyn-
geal carcinomata. He failed to detect,
however, Herpes siinplex 2 in cervical tum-
ours in spite of the extens-ive evidence of an
association between them. Martin and Weiss
give a general account of the evolution and
genetics of oncorna viruses -which they use
as the basis of tfheir own versioin of the onco-
gene-protovirus hypothesis. McCarter, Ball
and Wong conclude that the leukaemic and
sarcoma virus of the mouse (MLV and MSV)
can be regarded as recombinants ofeach other.
E1tirowtmentalcarcinoyenesis
Newcombe advocates the use of new
comiiputer technology for the complete pros-
pective recording of the population of a
proviince or even nation as the basis for
epidemiological studies. Koestner presents
evidence of transplacental carcinogenesis in
the rat with MNU and ENU. Stich et al.,
in a general account of DNA repair processes,
advocate their use to detect carcinogens, but
the rate of repair of DNA is equally depen-
dent on the amount of damage sustained and
the efficiency of repair processes. Thus,
for a knowNn carcinogen, the amount of DNA
repair would be inversely related to the
carcinogenicity.
Tunmour immunoloyy
This topic is favoured writh t,wo cliniical
papers. Lewis has studied autologous anti-
bodies in melanoma. He concludes that
their presence delays metastasis and they are
therefore the key to the control ofthe disease.
Powles gives the shortest paper in the con-
ference but it is probably the one of the
greatest interest to clinicians. It describes
the prolongation of remission (not cure) of
myelogenous leukaemia by stimulating the
patients' immune response with a combina-
tion of B.C.G. and irradiated allogeneic mnye-
loblastic leukaemic cells. Prehn airs his
scepticism of immunological surveillance as
the natural method of controlling cancer.
He avers that the patients' immune response
to a tumour is both too little and too Iate.
Chemotherapy
Hall argues for a more scientific approach
to the selection of chemicals and particularly
of combinations of chemicals for clinical use.
Bruce criticizes the criterion of size alone as
a measure of the response of an animal tumn-
our to treatment and recommends the use of
transplantability also as a measure of its
viability. LePage describes successes in
chemotherapy by a combination of a sophis-
ticated thioguanine derivative (/l-2'-deoxy-
thioguanosine) and cytosine arabinoside.
This slim volume is luxuriously produced
and expensive. It is no doubt a boost to
the morale of Canadian cancer research
(though half of the 12 papers are from non-
Canadian laboratories). One would expect
most of the material to appear elsewhere
before or after the conference. It is doubtful
therefore whether it makes a w%orthwhile
contribution to the wNorld literature on cancer
research.
A. J. BATEMAN
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